Krystal Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $96,042 | $88,183 | $91,139 | $83,841 |
Gross Profit | 87,334 | 83,155 | 86,190 | 77,157 |
EBITDA | 39,307 | 37,811 | 42,934 | 31,257 |
EBIT | 36,177 | 41,346 | 29,728 | |
Net Income | 38,333 | 35,733 | 45,479 | 27,180 |
Net Change In Cash | 96,042 | 88,183 | 91,139 | 83,841 |
Free Cash Flow | 50,825 | 24,765 | 52,042 | 57,811 |
Cash | 353,829 | 308,770 | 344,865 | 373,966 |
Basic Shares | 29,749 | 29,871 | 29,883 | 29,902 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $290,515 | $50,699 | $0 | $0 |
Gross Profit | 270,454 | 47,605 | -4,055 | -2,769 |
EBITDA | 109,909 | 17,904 | -145,196 | -65,309 |
EBIT | 103,162 | 12,897 | -149,251 | -68,078 |
Net Income | 89,159 | 10,932 | -139,975 | -69,570 |
Net Change In Cash | 290,515 | 50,699 | 0 | 0 |
Cost of Revenue | 72,977 | |||
Free Cash Flow | 119,182 | -100,603 | -153,548 | -116,274 |
Cash | 344,865 | 358,328 | 161,900 | 341,246 |
Basic Shares | 29,740 | 27,751 | 25,491 | 22,196 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $1.29 |
2025-03-31 | $1.19 |
2024-12-31 | $1.53 |
